Detalhe da pesquisa
1.
Inhibition of CHK1 and WEE1 as a new therapeutic approach in diffuse large B cell lymphomas with MYC deregulation.
Br J Haematol
; 181(1): 129-133, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28025833
2.
Identification of PLK1 as a New Therapeutic Target in Mucinous Ovarian Carcinoma.
Cancers (Basel)
; 12(3)2020 Mar 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-32183025
3.
DNA Damage Response Inhibitor Combinations Exert Synergistic Antitumor Activity in Aggressive B-Cell Lymphomas.
Mol Cancer Ther
; 18(7): 1255-1264, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31064869
4.
Combining Ibrutinib with Chk1 Inhibitors Synergistically Targets Mantle Cell Lymphoma Cell Lines.
Target Oncol
; 13(2): 235-245, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29441438
5.
Identification of small-molecule EGFR allosteric inhibitors by high-throughput docking.
Future Med Chem
; 10(13): 1545-1553, 2018 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29766737
6.
BET bromodomain inhibitor birabresib in mantle cell lymphoma: in vivo activity and identification of novel combinations to overcome adaptive resistance.
ESMO Open
; 3(6): e000387, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30305939
7.
Structure-Activity Relationships of Hexahydrocyclopenta[c]quinoline Derivatives as Allosteric Inhibitors of CDK2 and EGFR.
ChemMedChem
; 13(24): 2627-2634, 2018 12 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-30457710
8.
Probing an Allosteric Pocket of CDK2 with Small Molecules.
ChemMedChem
; 12(1): 33-41, 2017 01 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-27860401
9.
Characterization of a mantle cell lymphoma cell line resistant to the Chk1 inhibitor PF-00477736.
Oncotarget
; 6(35): 37229-40, 2015 Nov 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-26439697
10.
Combined inhibition of Chk1 and Wee1 as a new therapeutic strategy for mantle cell lymphoma.
Oncotarget
; 6(5): 3394-408, 2015 Feb 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-25428911